Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy

[Image: see text] Pancreatic cancer (PanCa) is a highly lethal disease with a poor 5 year survival rate, less than 7%. It has a dismal prognosis, and more than 50% of cases are detected at an advanced and metastatic stage. Gemcitabine (GEM) is a gold standard chemotherapy used for PanCa treatment. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetty, Advait, Nagesh, Prashanth K.B., Setua, Saini, Hafeez, Bilal B., Jaggi, Meena, Yallapu, Murali M., Chauhan, Subhash C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178800/
https://www.ncbi.nlm.nih.gov/pubmed/32337462
http://dx.doi.org/10.1021/acsomega.0c00793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178800/
https://www.ncbi.nlm.nih.gov/pubmed/32337462
http://dx.doi.org/10.1021/acsomega.0c00793

Ejemplares similares